David T Evans Selected Research

Fc(alpha) receptor

1/2022	Anti-SARS-CoV-2 IgG and IgA antibodies in COVID-19 convalescent plasma do not enhance viral infection.
9/2021	Anti-SARS-CoV-2 IgG and IgA antibodies in COVID-19 convalescent plasma do not facilitate antibody-dependent enhance of viral infection.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

David T Evans Research Topics

Disease

30	Infections 01/2022 - 03/2004
7	Virus Diseases (Viral Diseases) 01/2022 - 01/2010
5	Viremia 11/2018 - 01/2010
5	Acquired Immunodeficiency Syndrome (AIDS) 11/2018 - 12/2012
4	COVID-19 01/2022 - 01/2021
3	Communicable Diseases (Infectious Diseases) 01/2022 - 09/2015
3	Persistent Infection 01/2019 - 12/2013
1	Disease Progression 01/2018
1	Coinfection 07/2015
1	Neoplasms (Cancer) 03/2011
1	HIV Infections (HIV Infection) 02/2003

Drug/Important Bio-Agent (IBA)

14	VaccinesIBA 01/2022 - 02/2003
9	AntibodiesIBA 01/2022 - 10/2010
6	Immunoglobulin G (IgG)IBA 01/2022 - 10/2011
6	LigandsIBA 01/2022 - 03/2011
6	EpitopesIBA 01/2018 - 03/2004
5	Immunoglobulin A (IgA)IBA 01/2022 - 04/2012
5	Bone Marrow Stromal Antigen 2IBA 01/2020 - 12/2013
3	Monoclonal AntibodiesIBA 01/2022 - 01/2019
3	Viral ProteinsIBA 01/2017 - 11/2004
2	Fc(alpha) receptorIBA 01/2022 - 09/2021
2	Protein SIBA 01/2022 - 09/2021
2	Virus ReceptorsIBA 01/2022 - 09/2021
2	Fc gamma receptor IIAIBA 01/2022 - 09/2021
2	Immunoglobulin M (IgM)IBA 01/2022 - 09/2021
2	Antiviral Agents (Antivirals)IBA 07/2017 - 01/2016
2	Broadly Neutralizing AntibodiesIBA 01/2017 - 10/2011
2	Neutralizing AntibodiesIBA 01/2017 - 07/2011
2	Glycoproteins (Glycoprotein)IBA 01/2017 - 01/2008
2	Proteins (Proteins, Gene)FDA Link 12/2016 - 04/2012
2	AIDS VaccinesIBA 07/2011 - 06/2005
1	DNA (Deoxyribonucleic Acid)IBA 01/2019
1	Ribosomal DNA (rDNA)IBA 01/2019
1	Viral RNAIBA 01/2018
1	HLA-DR Antigens (HLA-DR)IBA 07/2017
1	Fc Receptors (Fc Receptor)IBA 09/2014
1	Interferon-alpha (Interferon Alfa)IBA 12/2013
1	LuciferasesIBA 11/2012
1	Immunoglobulin Fc FragmentsIBA 10/2011
1	Immunoglobulins (Immunoglobulin)IBA 03/2011
1	Peptides (Polypeptides)IBA 03/2011
1	HLA-C Antigens (HLA-C)IBA 07/2010
1	Messenger RNA (mRNA)IBA 07/2010
1	Indicators and Reagents (Reagents)IBA 01/2010
1	Chemokine ReceptorsIBA 01/2008
1	ElementsIBA 07/2006
1	Contraceptive Agents (Contraceptives)IBA 07/2006
1	AS 35IBA 06/2005
1	RNA (Ribonucleic Acid)IBA 06/2005

Therapy/Procedure

6	Therapeutics 01/2022 - 12/2012
1	Transplantation 01/2022
1	Immunotherapy 01/2016
1	Condoms (Condom) 07/2006